All issues
Volume 51 (2000 - 200･･･
- Issue 5 Pages 817-
- Issue 4 Pages 523-
- Issue 3 Pages 347-
- Issue 2 Pages 185-
- Issue 1 Pages 1-
Volume 51, Issue 3
Displaying 1-9 of 9 articles from this issue
- |<
- <
- 1
- >
- >|
-
Kunio Matsuda2000 Volume 51 Issue 3 Pages 347-357
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (5175K) -
Itsuo NISHIOKA2000 Volume 51 Issue 3 Pages 359-374
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (1791K) -
Takeshi MIYATA2000 Volume 51 Issue 3 Pages 375-397
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (18932K) -
2000 Volume 51 Issue 3 Pages 399-435
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (23896K) -
Iwao HYODO2000 Volume 51 Issue 3 Pages 437-446
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSA study of 16 cases of glossodynia based on the Kampo diagnosis “Sho”, treated by the department of Oral Surgery, Gifu University School of Medicine was performed between February 1995 and February 1998.
There were three males and 13 females with glossodynia. The patients ranged in age from 44 to 75. The total number of Chinese medicine (Kampo medicines) which we used were Kami-shoyo-san for 8 cases, Ninjin-yoei-to for 6 cases, Rikko-san for 5 cases, Ninjin-to and Kihi-to for 4 cases, and Oren-gedoku-to for 3 cases; Hange-byakujutsu-temma-to, Gorei-san, Kambaku-taiso-to, Juzen-taiho-to and Sansonin-to for 2 cases respectively; Sho-kenchu-to, Koso-san, Ryutan-shakan-to, Sairei-to, Chorei-to, San'o-shashin-to, Gosha-jinki-gan, and Seishin-renshi-in for 1 case respectively. The administration period was between 16 and 396 days.
Glossodynia is still not well understood. However, the treatment based on Sho was effective.View full abstractDownload PDF (2674K) -
Kenji NIWA, Midori HASHIMOTO, Teruhiko TAMAYA2000 Volume 51 Issue 3 Pages 447-454
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSWe investigated the clinical effect of Juzen-taiho-to and macrophage-colony stimulating factor (M-CSF) on thrombocytopenia induced by anti-cancer chemotherapy in gynecologic malignancies. We discussed 31 courses in 20 patients. Juzen-taiho-to and/or M-CSF were given when indicated from serum platelet level. Twenty-eight courses (90.3%) in 17 patients did not need transfusion of platelet, and 3 courses in 3 patients needed it. It suggested that Juzen-taiho-to and M-CSF might be effective. As platelet-free plasma TGF-β1 level during the treatment of Juzen-taiho-to alone was remarkably increased, it might enhance the antitumoral action. Accordingly, combination treatments of Juzen-taiho-to and M-CSF might be effective for thrombocytopenia induced by anti-cancer chemotherapy.View full abstractDownload PDF (805K) -
Yuji SHIOTANI, Takuhiro SHINTANI, Yutaka SHIMADA, Hirozo GOTO, Katsuto ...2000 Volume 51 Issue 3 Pages 455-460
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSZentai (Cicadae Periostracum) is classified by traditional Chinese medicine as one of the “pungent cool-natured” drugs, but its pharmacological action is not well known yet.
Zentai is used in Shofu-san as an expelling pathogenic wind component for relieving itchiness for patients with eczema, dermatitis, urticaria, etc.
We examined a number of patients with atopic dermatitis whose condition worsened after they were treated with Zentai to relieve itchiness.
In the current study, five male and ten female adolescent/adult patients were randomly selected to receive 2.5g of Zentai. These patients had been treated with Kagen-ichiin-sen-ka-kiban-kyo and their skin conditions had been stable so far.
In a follow-up two weeks later, the water content of the horny layer of skin at the forehead and the anterior side of the forearm decreased significantly (p<0.05). In terms of the level of itchiness, two patients (13.3%) improved, nine patients (60%) worsened, and the other four (26.7%) remained unchanged.
The current study indicates that Zentai worsens dry skin and exacerbates itchiness. Care will be required in the use of Zentai for the treatment of atopic dermatitis because of its drying pharmacological character.View full abstractDownload PDF (702K) -
Shuji YAKUBO, Yukio OZAWA, Katsuo KANMATSUSE2000 Volume 51 Issue 3 Pages 461-467
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSHochu-ekki-to is one type of medicine that improves a Ki-deficiency. We therefore investigated the effects of Hochu-ekki-to on symptoms indicating a state of Ki-deficiency. In addition, we studied the effects of Hochu-ekki-to on blood pressure or body temperature. We studied 14 adult male patients with symptoms of general fatigue, lack of will power and appetite loss. We orally administered 7.5g of Hochu-ekki-to extract fine granules (EK-41) (Kanebo Pharm. Co, Tokyo, Japan) per day for four weeks. Before the oral administration of EK-41, and again four weeks later, we investigated any improvement of symptoms, and changes in the blood pressure or body temperature. After the oral administration of EK-41 for four weeks the general fatigue or lack of will power improved significantly (p<0.05), and we observed a significant increase in body temperature (p<0.05). The over all rate of “improvement” was 57.1%, and the rate for “slight improvement or more” was 71.4%. The oral administration of Hochu-ekki-to not only improved the symptoms of general fatigue and lack of will power but also raised the body temperature. This leads us to suspect that Hochu-ekki-to increased the metabolic function. We therefore consider the oral administration of Hochu-ekkito to be useful for the treatment of Ki-deficiency state patients with the symptoms of general fatigue and lack of will power.View full abstractDownload PDF (754K) -
The Current Research Movement on Complementary and Alternative MedicineHitoshi YAMASHITA, Hiroshi TSUKAYAMA, Yasuo TANNO2000 Volume 51 Issue 3 Pages 469-478
Published: November 20, 2000
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSWe introduce the current research on complementary and alternative medicine (CAM) in the West, which we refer to as Evidence-based CAM (EBCAM), and discuss its characteristics, problems, and perspectives. Compared with the common attitude of CAM researchers in Japan, that of EBCAM researchers is more objective and often self-critical. EBCAM research is still developing because randomized controlled trials on CAM have many methodological flaws. Caution should be employed in interpreting provisional conclusions of relevant systematic reviews. CAM researchers in Japan should view the case report method from a perspective other than efficacy. Also, they will have to prepare evidence in response to demands from CAM consumers. Priority of research subjects from various kinds of CAM should be decided according to their popularity. Therefore, a large-scale survey on CAM use in Japan is essential.View full abstractDownload PDF (1189K)
- |<
- <
- 1
- >
- >|